TAMs are generally polarized into either of two extremes, classical activated M1 subtype and alternatively activated M2 subtype. TAMs usually express an M2-like phenotype and participate in tumor angiogenesis, tumor invasion, tumor metastasis, and immunosuppression. Reprogramming TAMs toward M1-like macrophages would thus be an efficient way to promote tumor regression. Integrating a state-of-the-art macrophage therapeutics development platform as well as industry-leading expertise in TAM reprogramming, Creative Biolabs is committed to providing overall solutions, focusing on innovative research. Our scientists are fully competent and dedicated to helping our clients' research and project development.
Plasticity and diversity allow their classification along an M1-M2 polarization axis. TAMs can be educated by the tumor microenvironment they experience, providing multiple phenotypes with a broad range of functions. The polarization of macrophages can be driven by different microenvironmental molecules and leads to the production by macrophages of different cytokines and chemokines.
TAMs usually exhibit an M2 phenotype and thus promote tumor progression, metastasis, and resistance to therapy. Therefore, there is a key interest to create strategies for reprogramming TAMs from M2-like to an M1-like phenotype and thereby induce immune effects that can bring about tumor regression.
Fig.1 Macrophage polarization.1,2
Several strategies are being explored to reprogram TAMs:
Creative Biolabs offers TAM reprogramming services, leveraging our expertise and cutting-edge technologies to support research and project development in this field. These services typically include:
Reprogramming TAMs with Nanomedicine
Nanoparticles are fine-tuned nanoscale materials for drug delivery and diagnosis. Various functionalized nanomedicines have been designed to repolarize TAM from pro-tumorigenic M2-like to tumoricidal M1-like macrophages. Creative Biolabs has developed several efficient strategies to reprogram TAMs to M1 phenotype with nanomedicines.
Reprogramming TAMs by Targeting Signaling Pathway
There are several mechanisms involved in macrophage polarization, which provides an intriguing opportunity to reprogramming tumor-promoting M2-like TAMs toward tumoricidal M1 phenotype. Creative Biolabs has perfected our technical pipelines in reprogramming TAMs to M1 phenotypes by targeting signaling pathways.
Reprogramming TAMs with Anticancer Therapies
Targeting the reprogramming of TAMs toward M1-like macrophages can be achieved through therapies including chemical compounds or immunotherapy, such as Toll-like receptors (TLRs), stimulator of interferon genes (STING) agonists and monoclonal antibody (mAbs). Targeting macrophage reprogramming could also synergize their effects on tumor regression.
Reprogramming TAMs by Monoclonal Antibodies (mAbs)
M2 macrophages may be repolarized to M1 macrophages by altering specific cytokines in a tumor. This can be implemented by mAbs, such as anti-CSF1R, anti-CCL2, anti-CD47 or anit-signal regulatory protein alpha (SIRPα) signaling mAbs. Creative Biolabs is committed to providing overall solutions for TAM reprogramming by mAbs, focusing on innovative research.
Creative Biolabs offers turn-key or ala carte services customized to our client's needs. Please contact us for more information and a detailed quote.
With the deepening of TAM research, we found that many researchers need more refined tools to manipulate and analyze macrophages. For this reason, we have developed a series of scientific products dedicated to macrophage research.
Below are some of our popular products. You can click to view the details.
Cat.No | Product Name | Product Type |
---|---|---|
MTS-0922-JF10 | Human Macrophages, Alveolar | Human Macrophages |
MTS-0922-JF99 | Human M0 Macrophages, 1.5 x 10^6 | Human M0 Macrophages |
MTS-0922-JF52 | C57/129 Mouse Macrophages, Bone Marrow | C57/129 Mouse Macrophages |
MTS-0922-JF7 | Human M2 Macrophages, Peripheral Blood, 10 x 10^6 | Human M2 Macrophages |
MTS-0922-JF34 | CD1 Mouse Macrophages | CD1 Mouse Macrophages |
MTS-1123-HM6 | Macrophage Colony Stimulating Factor (MCSF) ELISA Kit, Colorimetric | Detection Kit |
MTS-1123-HM15 | Macrophage Chemokine Ligand 19 (CCL19) ELISA Kit, qPCR | Detection Kit |
MTS-1123-HM17 | Macrophage Chemokine Ligand 4 (CCL4) ELISA Kit, Colorimetric | Detection Kit |
MTS-1123-HM49 | Macrophage Migration Inhibitory Factor (MIF) ELISA Kit, Colorimetric | Detection Kit |
MTS-1123-HM42 | Macrophage Receptor with Collagenous Structure ELISA Kit, Colorimetric | Detection Kit |
Q: How exactly does the TAM reprogramming service work? Can you briefly describe the process?
A: Our TAM reprogramming service transforms the phenotype of target cells into the desired type through specific experimental techniques. First, we will introduce reprogramming factors using viral vectors and then culture these cells under specific conditions. Next, we will monitor key indicators during the reprogramming process and perform the necessary optimizations to ensure that the cells are successfully reprogrammed.
Q: What kind of samples do I need to provide for the reprogramming process? Is there a sample size requirement?
A: We recommend that our customers provide a certain amount of cell samples, usually 1x106 cells, to ensure that we have enough cells for the experiment.
Q: What types of research is this service applicable to? Is there a specific area of application?
A: TAM reprogramming service is widely used in regenerative medicine, drug screening and disease model development. It is particularly suitable for laboratories that need to study cell fate transition and cell function.
Q: Can I follow the progress of my experiment during the reprogramming process? How can I access the experimental data?
A: Yes, we provide our customers with regular reports on the progress of their experiments, including key data and analysis results during the reprogramming process. The data can be accessed in real-time through our platform, and clients can communicate with our science team at any time.
References
Copyright © 2025 Creative Biolabs. All Rights Reserved.